丽珠集团7月27日公告,丽珠制药厂生产的单硝酸异山梨酯片通过仿制药质量和疗效一致性评价。截至本公告披露日,单硝酸异山梨酯片一致性评价已累计投入的直接研发费用约为752.61万元。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.